Testing effectiveness (Phase 2)WithdrawnNCT03880279What this trial is testingAutologous TAC T Cells Targeting CD19 in R/R Large B-Cell LymphomaWho this might be right forLymphoma, B-Cell Triumvira Immunologics, Inc.
Very early researchLooking for participantsNCT07429461What this trial is testingClinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic LeukemiaWho this might be right forB-Cell Acute Lymphoblastic Leukemia Zhejiang University 16
Early research (Phase 1)Active Not RecruitingNCT01695941What this trial is testingAlisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT06927466What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.Who this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT03808610What this trial is testingLow-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more M.D. Anderson Cancer Center 53
Large-scale testing (Phase 3)Looking for participantsNCT07479797What this trial is testingStudy Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line TherapyWho this might be right forRelapsed or Refractory Large B-cell Lymphoma Kite, A Gilead Company 550
Testing effectiveness (Phase 2)UnknownNCT03321123What this trial is testingMB-CART19.1 in Patients With R/R ALLWho this might be right forPrecursor B-Lymphoblastic Lymphoma/Leukaemia Refractory Shanghai Children's Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Very early researchLooking for participantsNCT06693973What this trial is testingAn Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Testing effectiveness (Phase 2)Looking for participantsNCT04502394What this trial is testingSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLLWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Kartos Therapeutics, Inc. 84
Early research (Phase 1)Study completedNCT03955783What this trial is testingVenetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic MalignanciesWho this might be right forDiffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma Sanjay Mohan 78
Early research (Phase 1)UnknownNCT04684472What this trial is testingModified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell MalignanciesWho this might be right forRefractory B-Cell Non-Hodgkin LymphomaRefractory Leukemia Liqun Zou 18
Testing effectiveness (Phase 2)Study completedNCT03484702What this trial is testingTrial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-Hodgkin Celgene 113
Very early researchNot Yet RecruitingNCT04609241What this trial is testingCD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed and/or Refractory Acute Lymphoblastic LeukemiaRelapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma Zhejiang University 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07122609What this trial is testingPirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed and Refractory DLBCL Ruijin Hospital 22
Testing effectiveness (Phase 2)Study completedNCT01381692What this trial is testingBortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular LymphomaWho this might be right forRecurrent Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone Lymphoma+8 more National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)WithdrawnNCT05929716What this trial is testingAn Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell LymphomaWho this might be right forLarge B-cell LymphomaB-cell Lymphoma M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT05515406What this trial is testingInvestigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLLWho this might be right forLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell Ono Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)WithdrawnNCT06005649What this trial is testingClinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forNon-hodgkin Lymphoma Juventas Cell Therapy Ltd.
Early research (Phase 1)Study completedNCT05359211What this trial is testingNKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+6 more Fred Hutchinson Cancer Center 27